1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015
2. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology. breast cancer, version 3.2014. http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 5/15/14.
3. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology. ovarian cancer, version 3.2014. http://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf. Accessed 5/15/14.
4. Lindor NM, Friedman S, Guidugli L, et al. Progress in clinical interpretation of DNA variants of undetermined significance in BRCA1/2. Based on a publication titled "A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)." 222.mayo.edu/research/document/brca-riskpdf/doc-10026644.
5. Morris G. Assessing genetic variants of undetermined significance: the example of breast cancer. 2013. www.els.net/WileyCDA/EIsArticle/refld-a0025220.html.